Supernus Announces Record Second Quarter 2017 Financial Results
Aug 02, 2017 20:15 pm UTC| Business
Second quarter net product sales were $73.3 million, a 46% increase over 2016.Strong acceleration in Trokendi XR prescription growth following April launch in migraine prophylaxis in adults and adolescents.Second quarter...
HCI Group Reports Second Quarter and Six-Month 2017 Results
Aug 02, 2017 20:15 pm UTC| Business
TAMPA, Fla., Aug. 02, 2017 -- HCI Group, Inc. (NYSE:HCI), a holding company primarily engaged in homeowners’ insurance with additional operations in reinsurance, real estate and information technology, reported results...
Summer Infant Reports Second Quarter Results
Aug 02, 2017 20:15 pm UTC| Business
WOONSOCKET, R.I., Aug. 02, 2017 -- Summer Infant, Inc. ("Summer Infant" or the "Company") (NASDAQ:SUMR), a global leader in premium infant and juvenile products, today announced financial results for the fiscal second...
Aug 02, 2017 20:15 pm UTC| Business
THE WOODLANDS, Texas, Aug. 02, 2017 -- Nexeo Solutions, Inc. (NASDAQ:NXEO) announced today that it will hold its third quarter fiscal year 2017 earnings conference call on Wednesday, August 9, 2017 at 9:00 a.m. CT...
Mercury Systems to Present at the Jefferies 2017 Industrials Conference
Aug 02, 2017 20:15 pm UTC| Business
ANDOVER, Mass., Aug. 02, 2017 -- Mercury Systems, Inc. (NASDAQ:MRCY) (www.mrcy.com) announced that it will participate in the Jefferies 2017 Industrials Conference to be held Aug. 7-9, 2017 in New York. Management will...
Uniti Group Inc. Declares $0.60 Per Share Quarterly Dividend
Aug 02, 2017 20:15 pm UTC| Business
LITTLE ROCK, Ark., Aug. 02, 2017 -- Uniti Group Inc. (“Uniti”) (Nasdaq:UNIT), today announced that its Board of Directors declared a quarterly cash dividend of $0.60 per share, payable on October 13, 2017 to...
Aug 02, 2017 20:15 pm UTC| Business
WATERTOWN, Mass., Aug. 02, 2017 -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical-stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections,...